Rapid screening and scaled manufacture of immunogenic virus-like particles in ALiCE
VLPs are a promising alternative to traditional vaccine platforms. In this poster, we present scaled VLP production (up to 100,000 vaccine doses) in ALiCE.
Facile scaling of eukaryotic cell-free protein synthesis
We present data showcasing the scaling of the ALiCE cell-free protein expression reaction from microliters to liters, with no reduction in protein yields.
How-to guide
Are you considering a transition from a cell-based to a cell-free expression system? This guide will help you.
Step-by-Step guide
Get a comprehensive step-by-step guide on how our protein service works to address all your protein needs.